Literature DB >> 29737564

IL-1β from M2 macrophages promotes migration and invasion of ESCC cells enhancing epithelial-mesenchymal transition and activating NF-κB signaling pathway.

Jian Zhou1,2, Shutao Zheng2,3, Tao Liu2,3, Qing Liu2,3, Yumei Chen1,2, Doudou Tan1,2, Rong Ma1,2, Xiaomei Lu1,2.   

Abstract

Despite the phenotype has been established that M2 macrophages promotes the metastasis of ESCC, question still remains as to how the M2 macrophages facilitated metastasis of ESCC cells. To begin with, immunohistochemistry was performed to detect the expression of CD163, one typical surface marker of M2 macrophages in 90 paired ESCC and its normal controls after meta-analyzing the relevant studies regarding M2 macrophages in ESCC, confirming that infiltration of M2 macrophages was significantly linked with lymph node metastasis, T classification, and inferior overall survival of ESCC. To explore the mechanism behind, protein factors secreted by M2 macrophages were identified using antibody microarray. Six different significantly differential protein factors were screened out, including IL-1β, TIMP1, IL-1α, MDC, TGF-β1, and TGF-β2. Among which, IL-1β was picked up as cytokine as interest based on previous reports and its absolute fold. Functional analysis of IL-1β showed that IL-1β was able to promote migration and invasion of ESCC cells, enhancing epithelial-mesenchymal transition, and activating NF-κB pathway. Our study supports the promoting role of M2 macrophages in metastasis of ESCC cells, enriching the profile of protein factors released from M2 macrophages.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT; IL-1β; M2 macrophages; NF-κB; esophageal squamous cell carcinoma (ESCC)

Mesh:

Substances:

Year:  2018        PMID: 29737564     DOI: 10.1002/jcb.26918

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response.

Authors:  Xiaoxiao Liu; Xiaobo Shi; Wei Guo; Yue Ke; Yuxing Li; Shupei Pan; Xiaona Li; Mei Liu; Mingzhu Liu; Yuchen Wang; Qinli Ruan; Hongbing Ma
Journal:  Int J Gen Med       Date:  2021-09-18

2.  Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network.

Authors:  Takeshi Ieda; Hiroshi Tazawa; Hiroki Okabayashi; Shuya Yano; Kunitoshi Shigeyasu; Shinji Kuroda; Toshiaki Ohara; Kazuhiro Noma; Hiroyuki Kishimoto; Masahiko Nishizaki; Shunsuke Kagawa; Yasuhiro Shirakawa; Takashi Saitou; Takeshi Imamura; Toshiyoshi Fujiwara
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

3.  CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.

Authors:  Takayuki Kodama; Yu-Ichiro Koma; Noriaki Arai; Aya Kido; Naoki Urakawa; Mari Nishio; Manabu Shigeoka; Hiroshi Yokozaki
Journal:  Lab Invest       Date:  2020-05-26       Impact factor: 5.662

Review 4.  Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Authors:  Ajaz A Bhat; Sabah Nisar; Selma Maacha; Tatiana Correa Carneiro-Lobo; Sabah Akhtar; Kodappully Sivaraman Siveen; Nissar A Wani; Arshi Rizwan; Puneet Bagga; Mayank Singh; Ravinder Reddy; Shahab Uddin; Jean-Charles Grivel; Gyan Chand; Michael P Frenneaux; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Muzafar A Macha; Mohammad Haris
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

5.  Development of a prognostic signature for esophageal cancer based on nine immune related genes.

Authors:  Zhi Zhang; Cheng Chen; Ying Fang; Sheng Li; Xiaohua Wang; Lei Sun; Guoren Zhou; Jinjun Ye
Journal:  BMC Cancer       Date:  2021-02-04       Impact factor: 4.430

Review 6.  Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases.

Authors:  Maria K Skytthe; Jonas Heilskov Graversen; Søren K Moestrup
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

7.  An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.

Authors:  Xavier Tekpli; Tonje Lien; Andreas Hagen Røssevold; Daniel Nebdal; Elin Borgen; Hege Oma Ohnstad; Jon Amund Kyte; Johan Vallon-Christersson; Marie Fongaard; Eldri Undlien Due; Lisa Gregusson Svartdal; My Anh Tu Sveli; Øystein Garred; Arnoldo Frigessi; Kristine Kleivi Sahlberg; Therese Sørlie; Hege G Russnes; Bjørn Naume; Vessela N Kristensen
Journal:  Nat Commun       Date:  2019-12-03       Impact factor: 14.919

Review 8.  The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer.

Authors:  Man Wang; Shuai Jiang; Yinfeng Zhang; Peifeng Li; Kun Wang
Journal:  Cancers (Basel)       Date:  2019-09-05       Impact factor: 6.639

9.  IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics.

Authors:  Shengding Zhang; Yu Fan; Lu Qin; Xiaoyu Fang; Cong Zhang; Junqing Yue; Wenxue Bai; Gang Wang; Zhihong Chen; Harld Renz; Chrysanthi Skevaki; Xiansheng Liu; Min Xie
Journal:  Respir Res       Date:  2021-08-03

10.  CD11b+CTLA4+ myeloid cells are a key driver of tumor evasion in colorectal cancer.

Authors:  Hiroshi Imazeki; Yamato Ogiwara; Mami Kawamura; Narikazu Boku; Chie Kudo-Saito
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.